Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase

The mammalian target of rapamycin (mTOR) and phosphoinositide-3-kinase (PI3K) pathways are often aberrantly activated in acute myeloid leukemia (AML) and play critical roles in proliferation and survival of leukemia cells. We provide evidence that simultaneous targeting of mTOR complexes with the ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Colamonici, Marco, Blyth, Gavin, Saleiro, Diana, Szilard, Amy, Bliss-Moreau, Meghan, Giles, Francis J., Altman, Jessica K., Beauchamp, Elspeth M., Platanias, Leonidas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480735/
https://www.ncbi.nlm.nih.gov/pubmed/25823922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480735/
https://www.ncbi.nlm.nih.gov/pubmed/25823922

Ejemplares similares